The Apex Times
Above the Noise
Business Wire
BusinessAMD says Instinct AI systems are now operating in Saudi Arabia, highlighting a potential ramp tied to additional data-center powerThe Apex TimesBusinessCostco and Old Navy promotions, Apple leadership change, and other retail and tech themes surfaced in a market roundupThe Apex TimesBusinessDeere named among stocks making notable moves in late-Thursday trading recapThe Apex TimesBusinessSalesforce says AI-driven revenue momentum is building as Agentforce adoption spreadsThe Apex TimesBusinessSalesforce backs HiBob to bolster workforce AI, and adds a new AgentExchange email toolThe Apex TimesBusinessEverPass Media expands NFL distribution via multi-year Netflix deal for 2026 slateThe Apex TimesBusinessUnitedHealth shares rise as it moves to drop prior-authorization checks for about 30% of servicesThe Apex TimesBusinessBerkshire Hathaway CEO Greg Abel to Appear on TV in Rare Interview, With Focus Likely on Insurance and BNSFThe Apex TimesBusinessCoinbase expands Webull crypto trading footprint into CanadaThe Apex TimesBusinessBroadcom leans harder into VMware AI with a push aimed at enterprise rivalsThe Apex TimesBusinessModerna shares jump after GSK advances a rival mRNA flu vaccine to Phase IIIThe Apex TimesBusinessYahoo Finance points to “buy zones” for Microsoft, Palantir, Shopify and ServiceNowThe Apex TimesBusinessAMD says Instinct AI systems are now operating in Saudi Arabia, highlighting a potential ramp tied to additional data-center powerThe Apex TimesBusinessCostco and Old Navy promotions, Apple leadership change, and other retail and tech themes surfaced in a market roundupThe Apex TimesBusinessDeere named among stocks making notable moves in late-Thursday trading recapThe Apex TimesBusinessSalesforce says AI-driven revenue momentum is building as Agentforce adoption spreadsThe Apex TimesBusinessSalesforce backs HiBob to bolster workforce AI, and adds a new AgentExchange email toolThe Apex TimesBusinessEverPass Media expands NFL distribution via multi-year Netflix deal for 2026 slateThe Apex TimesBusinessUnitedHealth shares rise as it moves to drop prior-authorization checks for about 30% of servicesThe Apex TimesBusinessBerkshire Hathaway CEO Greg Abel to Appear on TV in Rare Interview, With Focus Likely on Insurance and BNSFThe Apex TimesBusinessCoinbase expands Webull crypto trading footprint into CanadaThe Apex TimesBusinessBroadcom leans harder into VMware AI with a push aimed at enterprise rivalsThe Apex TimesBusinessModerna shares jump after GSK advances a rival mRNA flu vaccine to Phase IIIThe Apex TimesBusinessYahoo Finance points to “buy zones” for Microsoft, Palantir, Shopify and ServiceNowThe Apex TimesBusinessAMD says Instinct AI systems are now operating in Saudi Arabia, highlighting a potential ramp tied to additional data-center powerThe Apex TimesBusinessCostco and Old Navy promotions, Apple leadership change, and other retail and tech themes surfaced in a market roundupThe Apex TimesBusinessDeere named among stocks making notable moves in late-Thursday trading recapThe Apex TimesBusinessSalesforce says AI-driven revenue momentum is building as Agentforce adoption spreadsThe Apex TimesBusinessSalesforce backs HiBob to bolster workforce AI, and adds a new AgentExchange email toolThe Apex TimesBusinessEverPass Media expands NFL distribution via multi-year Netflix deal for 2026 slateThe Apex TimesBusinessUnitedHealth shares rise as it moves to drop prior-authorization checks for about 30% of servicesThe Apex TimesBusinessBerkshire Hathaway CEO Greg Abel to Appear on TV in Rare Interview, With Focus Likely on Insurance and BNSFThe Apex TimesBusinessCoinbase expands Webull crypto trading footprint into CanadaThe Apex TimesBusinessBroadcom leans harder into VMware AI with a push aimed at enterprise rivalsThe Apex TimesBusinessModerna shares jump after GSK advances a rival mRNA flu vaccine to Phase IIIThe Apex TimesBusinessYahoo Finance points to “buy zones” for Microsoft, Palantir, Shopify and ServiceNowThe Apex TimesBusinessAMD says Instinct AI systems are now operating in Saudi Arabia, highlighting a potential ramp tied to additional data-center powerThe Apex TimesBusinessCostco and Old Navy promotions, Apple leadership change, and other retail and tech themes surfaced in a market roundupThe Apex TimesBusinessDeere named among stocks making notable moves in late-Thursday trading recapThe Apex TimesBusinessSalesforce says AI-driven revenue momentum is building as Agentforce adoption spreadsThe Apex TimesBusinessSalesforce backs HiBob to bolster workforce AI, and adds a new AgentExchange email toolThe Apex TimesBusinessEverPass Media expands NFL distribution via multi-year Netflix deal for 2026 slateThe Apex TimesBusinessUnitedHealth shares rise as it moves to drop prior-authorization checks for about 30% of servicesThe Apex TimesBusinessBerkshire Hathaway CEO Greg Abel to Appear on TV in Rare Interview, With Focus Likely on Insurance and BNSFThe Apex TimesBusinessCoinbase expands Webull crypto trading footprint into CanadaThe Apex TimesBusinessBroadcom leans harder into VMware AI with a push aimed at enterprise rivalsThe Apex TimesBusinessModerna shares jump after GSK advances a rival mRNA flu vaccine to Phase IIIThe Apex TimesBusinessYahoo Finance points to “buy zones” for Microsoft, Palantir, Shopify and ServiceNowThe Apex Times
Back to front
Johnson & Johnson says FDA has cleared AI features for MONARCH QUEST 3 bronchoscopy system
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 18, 11:34 AM EDT

Johnson & Johnson says FDA has cleared AI features for MONARCH QUEST 3 bronchoscopy system

The medical device company received U.S. regulatory clearance for a software update to its robotic-assisted bronchoscopy platform, adding AI-powered tools aimed at supporting clinicians during lung procedures.

By The Apex Times Newsroom2 min readAI-assisted Apex article

Johnson & Johnson (JNJ) said the U.S. Food and Drug Administration has cleared an AI-powered software update for its MONARCH QUEST 3 bronchoscopy system, a robotic-assisted device used to navigate airways to locate and access areas of the lung for diagnostic procedures.

MONARCH QUEST 3 is part of J&J’s Monarch platform, which combines imaging and automated guidance to help clinicians perform bronchoscopy with a more targeted approach than traditional manual methods. In this update, the company introduced new software capabilities intended to support the procedure through AI-powered tools.

According to the report, the FDA clearance covers MONARCH QUEST 3 software, rather than a new hardware system. That distinction matters because software clearances are typically tied to specific functions within a platform, with documentation focused on how the added tools perform and what changes they introduce to the device workflow.

The clearance was disclosed in a market-news write-up carried by Yahoo Finance. The item describes the update as “AI powered” and characterizes it as part of a software revision to the MONARCH QUEST 3 platform, implying J&J believes the AI tools are sufficiently validated for the intended clinical use under FDA rules.

J&J has been working to expand the footprint of its interventional pulmonology offerings as healthcare providers increasingly look for tools that can improve targeting and procedural efficiency. Devices like robotic bronchoscopy sit at the intersection of medical robotics and diagnostic imaging, where software improvements can be a recurring way to iterate capability without replacing the full device.

In the same vein, AI features in clinical devices are often positioned as decision-support or workflow-assist tools, designed to help practitioners interpret information and execute steps more consistently. Even when AI is included, the FDA approval generally reflects that the system’s performance and safety meet regulatory criteria for the specific claims and operating environment.

What the report does not detail is as important as what it states. It does not provide specifics on the exact AI functions included in the clearance, the nature of the AI outputs (for example, how the tools present guidance), the FDA decision date, or any study results or performance metrics underpinning the clearance.

Investors and clinicians will likely watch for additional company statements that clarify what the newly cleared AI tools do in practice, how they change the MONARCH QUEST 3 workflow, and when J&J expects the update to be broadly available in clinical settings.

Why It Matters

  • AI features are increasingly finding their way into regulated medical devices, and FDA clearance can accelerate adoption if clinicians and hospitals view the tools as practical and reliable.
  • Because the update is software-based, J&J may be able to iterate functionality on an installed base, potentially reducing friction compared with deploying wholly new hardware.
  • Robotic-assisted bronchoscopy is a competitive and clinically important area of interventional pulmonology, where software improvements can influence procedure outcomes and operational efficiency.
  • The next questions for the market are the scope of the AI functionality and evidence behind the clearance, which can affect both reimbursement discussions and purchasing decisions.

Sources

Key Facts

  • Johnson & Johnson said the FDA cleared an AI-powered software update for the MONARCH QUEST 3 bronchoscopy system.
  • MONARCH QUEST 3 is a robotic-assisted bronchoscopy platform used to navigate airways to access areas of the lung.
  • The clearance described relates to a software revision to the existing system rather than a newly announced hardware model.
  • The update is characterized as adding AI-powered tools intended to support clinicians during bronchoscopy procedures.
  • The disclosure was reported via Yahoo Finance. Details beyond the existence of clearance and AI-powered tools were not provided in the excerpted market-news item.

Healthcare Related